Stematix Obtains Exclusive License to Regenexx Stem Cell Procedure Treating Musculoskeletal Disorders in Latin America

    Stematix Inc., announced today it has signed an exclusive royalty-bearing license agreement, for the Latin American territory, to use an innovative process that rapidly grows a patients own adult stem cells to treat a variety of musculoskeletal diseases.

http://ow.ly/wuCl...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top